Article: Derma Sciences Closes $6.1 Million Private Placement.

Funds will accelerate sales force expansion

PRINCETON, N.J., April 3, 2008 /PRNewswire-FirstCall/ -- Derma Sciences Inc (BULLETIN BOARD: DSCI) , a provider of advanced wound care products, said that it has closed on its previously announced $6.1 million private placement with Lehman Brothers as well as new and existing investors. The net proceeds will be used to accelerate the expansion of the Derma Sciences sales force and to potentially broaden the scope of its licensing agreement with Comvita New Zealand, Ltd, its commercialization partner for MEDIHONEY(TM). Oppenheimer & Co. Inc. acted as advisor and placement agent.

Derma Sciences received $6.1 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!